The partnership combines AbTis' AbClick site-selective conjugation platform with WuXi XDC's all-in-one development and ...

WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, ...

What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing position in the biotechnology race with China has broader implications than just ...

WuXi Biologics has launched the E. coli expression system, EffiX, designed to enhance the production of recombinant proteins ...

WuXi has disputed an early WBJ report saying construction at the Worcester site has stopped, although the company declined to ...

Signs of China’s ascendance in biotechnology are everywhere ... The New York Times cited an estimate that the Chinese firm WuXi is involved in a quarter of all drugs used in the U.S. WuXi ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

In addition, as a participant of United Nations Global Compact (UNGC) and Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively contributes to advocating sustainability ...